LASIK Surgery Health Chat: Tuesday, December 15th 5:00-6:00 PM Eastern. Free live Q&A with Dr. Omar E Awad. Ask your question in advance!
Member Comments are provided by individuals and reflect their personal opinions only. Under NO circumstances should you act on any advice or opinion posted in this forum.  ALWAYS check with your personal physician before taking any action regarding your health! MedHelp International and our partners, sponsors and affiliates have no obligation to monitor any comments posted on this site, or the content and/or accuracy of such exchanges. MedHelp International does not endorse the views of any user.
STDs  (Expert Forum)
 | 
HPV clinical
Answered by
University of Washington Seattle - WA
Welcome to the STD Forum, which is intended only for questions and support pertaining to sexually transmitted diseases other than HIV/AIDS, including chlamydia, gonorrhea, syphilis, human papillomavirus, genital warts, trichomonas, other vaginal infections, nongonoccal urethritis (NGU), cervicitis, molluscum contagiosum, chancroid, and pelvic inflammatory disease (PID). All questions will be answered by H. Hunter Handsfield, M.D. or Edward W Hook, MD.

HPV clinical

by scaredsos, Oct 16, 2007 10:56AM
Hello Dr

Thanks for all your time and help. It really has meant a lot for me. I am a male and infected with HPV 16. I am about to participate in a research re: my HPV status, serology clearance, and manifestation of disease. I am contemplating getting gardasil. My question is if the antibody induced by gardasil for HPV 16 would interfere with their monitoring of my antibody for HPV 16 status to be done by the study?

Thanks again for your help

by H. Hunter Handsfield, M.D., Oct 16, 2007 04:34PM
Thanks for your willingness to serve as a study subject.  But don't blow it by being vaccinated without first checking with the researchers.  Getting the vaccine probably will interfere with the research.  Even if you don't tell them, they will know:  the antibody levels against HPV 16 are far higher after the vaccine than after natural infection.

In response to the comment by pcrguy, my guess is that you have already been tested as part of the research study.  But if not, his question is pertinent.  Do you know for sure?  How?

Best wishes--  HHH, MD
Member Comments (10)

by pcrguy, Oct 16, 2007 01:31PM
To: scaredsos
May I ask, how do you know you are infected with HPV 16? My understanding is there is no available test for men. Thanks.

by jda123, Oct 16, 2007 02:09PM
To: scaredsos
Why don't you ask the person conducting the study?

by scaredsos, Oct 16, 2007 04:28PM
I think I misspoke. I meant to say: in future, if I were to participate in a research that follows up a person's serology clearance and manifestation of disease.

by scaredsos, Oct 23, 2007 06:38AM
To: Dr
I am interested in getting Gardasil because I heard from physicians there might still be some benefit to people who are infected (despite the public announcement that it is only preventive and not therapeutic). Though Gardasil does not improve rate of clearance, Gardasil could prevent future malignancy for people already infected. What is your opinion on this?

Secondly, if antibody could not serve as an assessment tool, couldn't they follow the viral load of HPV 16 for evidence of clearance?

Thanks for your help.

by H. Hunter Handsfield, M.D., Oct 23, 2007 11:42PM
Gardasil has no effect whatsoever on established HPV infection.  It does not prevent future malignancy in people who already have HIV. Where on earth did you hear that?  

Tests for antibody and viral load are completely different tests.

by boy2, Oct 24, 2007 07:43AM
To: DR H
Any idea on the effectiveness of Gardasil after the second shot? Obviously, ideal would be after the full round, but do you think there is ANY effectiveness after the second shot of Gardasil?

Thanks

by scaredsos, Oct 31, 2007 12:39AM
To: doc
I got a little excited after reading this about Gardasil possible therapeutic value.

"For those already infected, the clinical trials suggested the (Gardasil) vaccine can cut the onset of pre-cancerous lesions, though the 27 per cent reduction achieved doesn't technically qualify for the rigid statistical nod of approval. "

http://www.smh.com.au/news/cancer/big-win-on-cancer/2006/02/08/1139379562005.html.?page=2

by H. Hunter Handsfield, M.D., Oct 31, 2007 08:49PM
Gardasil has no therapeutic value, and the article you quote doesn't say that it does.  The supposed 27% reduction refers to the impact on all HPV types.  For those covered by the vaccine, the protection is 100%; but there are many other types out there.  However, most of them are not associated with either cancer or warts, so they don't matter--they have no health implicaitons.

Most likely there is at least partial protection after the second shot. But everybody for sure should have the third dose.

by H. Hunter Handsfield, M.D., Oct 31, 2007 08:50PM
Related discussions
Continue discussion
RSS Expert Activity
Simple tool to Assess your Risk for...
6 hrs ago by Lee Kirksey, MD
Premium IOLs have a disproportionat...
20 hrs ago by John C Hagan III, MD, FACS
EyeNet Article about MedHelp.com Ey...
Dec 13 by John C Hagan III, MD, FACS